US Patent

US11357738 — Semifluorinated compounds and their compositions

Formulation · Assigned to Novaliq GmbH · Expires 2036-09-29 · 10y remaining

Vulnerability score 33/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects compositions of semifluorinated compounds for topical administration to the eye as medicaments.

USPTO Abstract

The present invention is directed to compositions comprising semifluorinated compounds and their use as medicaments for topical administration to the eye.

Drugs covered by this patent

Patent Metadata

Patent number
US11357738
Jurisdiction
US
Classification
Formulation
Expires
2036-09-29
Drug substance claim
No
Drug product claim
Yes
Assignee
Novaliq GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.